Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Sports
History
Fiction
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts115/v4/40/30/05/40300593-f17c-a6fb-fecb-c02363008aa8/mza_3063686816022121623.jpg/600x600bb.jpg
The Pharma Discourse
The Pharma Discourse
5 episodes
21 minutes ago
Brought to you by the student-led organization, Combat The Patent Prices, The Pharma Discourse tackles the serious issue of Big Pharma Patent Abuse and Price gouging. William, Ishaan, and Pranav discuss current pharmaceutical issues, healthcare policies, political discourse, and the need for affordable drug prices.
Show more...
Government
RSS
All content for The Pharma Discourse is the property of The Pharma Discourse and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Brought to you by the student-led organization, Combat The Patent Prices, The Pharma Discourse tackles the serious issue of Big Pharma Patent Abuse and Price gouging. William, Ishaan, and Pranav discuss current pharmaceutical issues, healthcare policies, political discourse, and the need for affordable drug prices.
Show more...
Government
https://d3t3ozftmdmh3i.cloudfront.net/production/podcast_uploaded_nologo/12792847/12792847-1613366123344-3ffb1ca609675.jpg
Abolition of Pharmaceutical Patents: Worth it?
The Pharma Discourse
17 minutes 22 seconds
4 years ago
Abolition of Pharmaceutical Patents: Worth it?

In this episode of "The Pharma Discourse," William & Ishaan discuss the pros and cons of the patents in the pharmaceutical industry and the potential effects of their abolition.

The Pharma Discourse
Brought to you by the student-led organization, Combat The Patent Prices, The Pharma Discourse tackles the serious issue of Big Pharma Patent Abuse and Price gouging. William, Ishaan, and Pranav discuss current pharmaceutical issues, healthcare policies, political discourse, and the need for affordable drug prices.